Wow, it never ends with this group. One gets a brain fart and another shows up in support. Last week mero stated the FDA would not approve a astx drug, because they would not understand the new technology. Where he dreams up that load of garbage.
This week he believes that Jhoti would do a better presentation than Dr. Manuso on epigenetics. Dr. M has been with dacogen and sgi-110 forever. Dr. jhoti just recently came on board on the astex buyout. His expertise is the astx pipeline.
The good point here is the panel discussion could be interesting.